SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as institutional ownership by major firms continues to surge, fueling active community speculation regarding an imminent buyout or positive data from the REGAL clinical trial. Investors are closely monitoring the status of the 80th trial event, with many debating the impact of upcoming filings and the potential for a market-moving catalyst as the company approaches its next earnings report.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas is trending as investors gear up for the upcoming earnings report, fueled by a string of high-profile defense and security contracts, including a recent deal to provide counter-drone protection for the Jacksonville Jaguars. Community discussion remains heavily focused on potential short squeeze dynamics and the company's aggressive acquisition strategy, with many supporters viewing recent contract wins as critical validation of its autonomous defense ecosystem.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as investors gear up for the upcoming top-line Phase 2 data readout for ABCL635, which is widely viewed as a pivotal clinical catalyst for the company's AI-assisted discovery platform. The community is actively debating the stock's potential for a short squeeze due to high short interest, while institutional analysts and investors monitor partnership momentum as a key validator of the company's long-term enterprise value.

RUM Group, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

RUM Group Inc. - Ordinary Shares - Class A

RUM Group Inc.

Rumble is trending as investors focus on the company's transformation into an AI infrastructure player following its Northern Data acquisition and strategic cloud deals, while community sentiment remains split between bullish anticipation of an earnings breakout and skepticism over current price action. Discussion is currently dominated by high short interest and the belief that the stock is significantly undervalued compared to the potential revenue growth from newly acquired data centers and GPUs.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as investors debate whether the recent consolidation marks a definitive bottom or a pause before a larger breakout, with sentiment heavily influenced by broader macroeconomic factors like interest rate expectations and the geopolitical landscape. The community remains focused on silver's critical role in AI infrastructure and industrial demand, while actively monitoring the stock's price action against key support levels and upcoming Fed developments.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund is experiencing heightened volatility and intense community debate as investors weigh near-term geopolitical risks against a complex, evolving diplomatic framework involving the Strait of Hormuz. While some participants are positioning for a potential long-term infrastructure and production shift, others remain focused on the impact of ongoing supply uncertainty and energy policy volatility.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as investors weigh its strong Q1 operational performance against potential headwinds from its Pakistan-based Reko Diq project. The community remains focused on the company's ability to navigate geopolitical risks while capitalizing on elevated gold prices through increased production and a new $3 billion share buyback program.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently rallying following a powerful Q2 earnings report that beat analyst expectations, driven by surging commercial revenue and sustained demand for its AI sovereignty tools. The stock's sharp upward momentum has triggered active community discussion regarding a potential short squeeze, as bullish investors emphasize the company's strong fundamental growth while bears contend with the stock's elevated valuation.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is capturing significant investor attention following the launch of its new venture fund and ongoing community discussion around its aggressive expansion into blockchain and tokenized asset services. Traders are actively debating whether the stock's recent volatility represents a structural shift or a prime entry point as technical indicators like the Golden Cross and various breakout levels become focal points for bullish sentiment.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as investors weigh strong prescription growth for its flagship dry eye product Vevye against management's historical volatility in forecasting revenue. Community discussions are centered on the upcoming earnings report, with sentiment divided between those betting on an institutional short squeeze driven by positive clinical data and those remaining cautious due to concerns over management's guidance credibility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KLA Corp. is currently trending as investors debate the sustainability of its AI-driven growth after a recent earnings report triggered a sharp pullback despite strong fundamental performance. Community sentiment is divided between those viewing the price drop as an attractive entry point into a near-monopoly player and others concerned about elevated valuations and broader semiconductor sector volatility.

AI Boom: Top Stocks to Consider for Your Portfolio

Here, we have picked three AI stocks, AMD, AMZN and KLAC, which are well-poised to benefit from AI's growing use and ability to solve complex problems.


Tesla-SpaceX Terafab Bet: 4 Chip Equipment Stocks That Could Benefit

Terafab buildout could create major opportunities for KLA, Onto, Applied Materials and Lam Research as AI chip capacity expands.

KLA Declares Regular Cash Dividend

KLA Declares Regular Cash Dividend KLA Declares Regular Cash Dividend PR Newswire MILPITAS, Calif., Aug. 6, 2026 MILPITAS, Calif., Aug. 6, 2026 /PRNewswire/ -- The KLA Corporation (NASDAQ: KLAC) Board of Directors today declared a quarterly cash dividend of $0.23 per share on its common stock...

Teradyne Is Overvalued at 10.36X PS: Should You Still Buy the Stock?

TER trades at a premium, but booming AI demand and strong growth in chip testing and robotics are powering its momentum.


Lam Research Plunges 16% in a Month: Should You Still Buy the Stock?

LRCX's 16% monthly fall contrasts with record revenues, strong AI equipment demand and rising earnings, strengthening the case for buying the stock.

ROK Q3 Earnings Beat Estimates on Margin Gains, FY26 View Hiked

Rockwell Automation tops Q3 earnings and revenue estimates as margin expansion boosts results, prompting it to raise its fiscal 2026 outlook.

ONTO Pre-Q2 Earnings: Buy the Stock Amid AI-Led Demand & HBM Momentum?

Onto Innovation heads into Q2 earnings with AI demand, advanced packaging growth and margin expansion in focus as investors watch for guidance.

Here's How Much $1000 Invested In KLA 20 Years Ago Would Be Worth Today

KLA (NASDAQ:KLAC) has outperformed the market over the past 20 years by 11.54% on an annualized basis producing an average annual return of 20.78%. Currently, KLA has a market capitalization of $238.66 billion.
Buyingread more...

Top Analyst Reports for Microsoft, Palo Alto Networks & American Express

Microsoft rides AI, Copilot and Azure growth, but can expanding cloud demand and capacity challenges shape its next phase?

KLA (KLAC) Upgraded to Strong Buy: What Does It Mean for the Stock?

KLA (KLAC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

$KLAC Q4 '26 Earnings Results & Recap

• Reported GAAP EPS of $1.04 up 14.29% YoY
• Reported revenue of $3.66B up 15.21% YoY
• KLA Corporation expects total revenues for the first quarter of fiscal 2027 to be in a range of $4.0 billion +/- $200 million, with GAAP diluted EPS of $1.14 +/- $0.10.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

AMSL, AMAT, KLAC, LRCX: Chipmaking Equipment Stocks Rise On Intel’s CapEx Bump

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '27	$1.18	--	--	N/A
Q4 '26	$1.00	$1.05	4.51%	BEAT
Q3 '26	$9.17	$0.94	-89.75%	MISSED
Q2 '26	$8.79	$8.85	0.67%	BEAT
Q1 '26	$8.63	$8.81	2.14%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '26

Historical Earnings